207 related articles for article (PubMed ID: 11331736)
1. Type 2 diabetes mellitus in children and adolescents.
Nesmith JD
Pediatr Rev; 2001 May; 22(5):147-52. PubMed ID: 11331736
[No Abstract] [Full Text] [Related]
2. Defining and characterizing the progression of type 2 diabetes.
Fonseca VA
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S151-6. PubMed ID: 19875543
[No Abstract] [Full Text] [Related]
3. Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.
Riddle MC
Diabetes Res Clin Pract; 1991 Jan; 11(1):3-8. PubMed ID: 2019232
[No Abstract] [Full Text] [Related]
4. Screening for type 2 diabetes in obese youth.
Shah S; Kublaoui BM; Oden JD; White PC
Pediatrics; 2009 Aug; 124(2):573-9. PubMed ID: 19620188
[TBL] [Abstract][Full Text] [Related]
5. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
Hay LC; Wilmshurst EG; Fulcher G
Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
[TBL] [Abstract][Full Text] [Related]
6. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude.
Wallace TM; Matthews DR
QJM; 2000 Jun; 93(6):369-74. PubMed ID: 10873187
[No Abstract] [Full Text] [Related]
7. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
Ohmura E; Hosaka D; Imai Y; Kawazu S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
[No Abstract] [Full Text] [Related]
8. Treatment of non-insulin-dependent diabetes mellitus.
Davidson MB
Mayo Clin Proc; 1997 Jan; 72(1):92. PubMed ID: 9005295
[No Abstract] [Full Text] [Related]
9. Clinical Prediction Tool To Identify Adults With Type 2 Diabetes at Risk for Persistent Adverse Glycemia in Hospital.
Kyi M; Gorelik A; Reid J; Rowan LM; Wraight PR; Colman PG; Fourlanos S
Can J Diabetes; 2021 Mar; 45(2):114-121.e3. PubMed ID: 33011129
[TBL] [Abstract][Full Text] [Related]
10. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.
Hammersley MS; Meyer LC; Morris RJ; Manley SE; Turner RC; Holman RR
Metabolism; 1997 Dec; 46(12 Suppl 1):44-9. PubMed ID: 9439559
[TBL] [Abstract][Full Text] [Related]
11. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus: customizing management.
Levin PA; McLaughlin J; Kowarski AA
Hosp Pract (Off Ed); 1984 Oct; 19(10):137-43, 147-9. PubMed ID: 6090485
[No Abstract] [Full Text] [Related]
13. [Tough glucose reduction necessary in newly diagnosed diabetes].
Rydén M
Lakartidningen; 2010 Nov 10-16; 107(45):2810-4. PubMed ID: 21179867
[No Abstract] [Full Text] [Related]
14. [Current methods of glucose metabolism control in diabetes mellitus].
Scarpitta AM; Sinagra D
Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
[TBL] [Abstract][Full Text] [Related]
15. Triple oral anti-diabetic therapy in type 2 diabetes.
Barnett AH
Diabet Med; 2003 Jan; 20 Suppl 1():14-6. PubMed ID: 12647835
[No Abstract] [Full Text] [Related]
16. [Diabetes mellitus of elderly patients: therapeutic recommendations].
Ben Amara H; Kacem A; Gaigi I; Dakhli S; Ben Mami F; Achour A
Tunis Med; 2008 Nov; 86(11):957-9. PubMed ID: 19213484
[TBL] [Abstract][Full Text] [Related]
17. Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes.
Erlinger TP; Brancati FL
Diabetes Care; 2001 Oct; 24(10):1734-8. PubMed ID: 11574434
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of carbohydrate metabolism disturbances in a population of children and adolescents with severe obesity].
Guijarro De Armas MG; Monereo Megias S; Civantos Modino S; Montaño Martínez JM; Iglesias Bolaños P; Durán Martínez M
Endocrinol Nutr; 2010 Dec; 57(10):467-71. PubMed ID: 21051299
[TBL] [Abstract][Full Text] [Related]
19. Postprandial hyperglycaemia--its importance and implications.
Lüddeke HJ
Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
[No Abstract] [Full Text] [Related]
20. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
Bell DS; Ovalle F
Endocr Pract; 2000; 6(4):293-5. PubMed ID: 11242605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
